Repurposing of anisomycin and oleandomycin as a potential anti-(SARS-CoV-2) virus targeting key enzymes using virtual computational approaches.
Cell Mol Biol (Noisy-le-grand)
; 67(5): 387-398, 2022 Feb 04.
Article
in En
| MEDLINE
| ID: mdl-35818229
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Journal:
Cell Mol Biol (Noisy-le-grand)
Journal subject:
BIOLOGIA MOLECULAR
Year:
2022
Type:
Article